# A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects

> **NCT01720537** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 133 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **BIOLOGICAL:** PF-05335810 Dose A
- **BIOLOGICAL:** PF-05335810 Dose B
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** PF-05335810 Dose B
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** PF-04950615 Dose A
- **BIOLOGICAL:** PF-04950615 Dose A
- **BIOLOGICAL:** PF-05335810 Dose C
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** PF-05335810 Dose C
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** PF-04950615
- **BIOLOGICAL:** PF-05335810 Dose D
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** PF-05335810 Dose E
- **BIOLOGICAL:** PF-05335810 Dose D
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01720537
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2018-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01720537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01720537, "A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01720537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*